Posted by Michael Wonder on 05 Aug 2015
[:content [\T \e \r \i \f \l \u \n \o \m \i \d \e \space \( \A \u \b \a \g \i \o \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \i \n \space \G \e \r \m \a \n \y \space \s \i \n \c \e \space \A \u \g \u \s \t \space \2 \0 \1 \3 \space \f \o \r \space \a \d \u \l \t \s \space \w \i \t \h \space \r \e \l \a \p \s \i \n \g \space \r \e \m \i \t \t \i \n \g \space \m \u \l \t \i \p \l \e \space \s \c \l \e \r \o \s \i \s \. \space \I \n \space \a \n \space \e \a \r \l \y " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Danish drugmaker Novo Nordisk, the world's biggest insulin producer, said on Wednesday it had decided to launch its diabetes drug ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Since September 2014, the fixed-dose combination of dolutegravir/abacavir/lamivudine (trade name Triumeq) has been approved for human immunodeficiency virus (HIV) infected ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Four years have passed since the introduction of the German Act on the Reform of the Market for Medicinal Products ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The European Commission on Friday cleared a German scheme that allowed exceptions to be made for pharmaceutical groups whose medicines ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Canagliflozin (Invokana) has been approved since November 2013 for use as monotherapy and in various combination therapies for adults with type 2 iabetes mellitus, ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
[:content [\1 \7 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \ \T \h \e \space \G \e \r \m \a \n \space \I \n \s \t \i \t \u \t \e \space \f \o \r \space \Q \u \a \l \i \t \y \space \a \n \d \space \E \f \f \i \c \i \e \n \c \y \space \i \n \space \H \e \a \l \t \h \space \C \a \r \e \space \( \I \Q \W \i \G \) \space \a \l \r \e \a \d \y \space \a \s \s \e \s \s \e \d \space \t \h \e \space \a \d \d \e \d \space \b \e \n \e \f \i \t \space \o \f " ..."]]
Read more →
Posted by Michael Wonder on 05 Aug 2015
Germany has come top of a new international league table in terms of access to medicines for patient organisations, with ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Germany’s IQWiG has concluded that Eisai’s breast cancer drug Halaven (erbulin mesylate) does indeed offer a benefit over other comparators on ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The Institute for Quality and Efficiency in Health Care (IQWiG) has completed the first step of the revision of its ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Gilead Sciences has finally agreed a price of for its hepatitis C virus (HCV) therapy Sovaldi with Germany's main health ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
The German Institute for Quality and Efficiency in Health Care (IQWiG) has assessed documents subsequently submitted by the drug manufacturer ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
2 January 2015 - Idelalisib (trade name Zydelig) has been available since September 2014 for use by patients with follicular lymphoma or chronic ...
Read more →
Posted by Michael Wonder on 05 Aug 2015
Daclatasvir dihydrochloride (trade name Daklinza) has been approved since August 2014 for the treatment of adults with chronic hepatitis C ...
Read more →